ISSUE #13 Oct 29, 2025

🎉 We successfully hosted BIOPLUS-INTERPHEX KOREA 2025 !

BIX continues to strengthen Korea’s position as a global biotech hub

through open innovation, industry collaboration, and global networking.

Mark your calendars and see you at BIX 2026 👋

KoreaBIO & Shonan iPark
signed MOU to drive Korea-Japan biotech collaboration and global innovation!
We ran Follow & Subscribe events at our BIX 2025 Booth to connect with visitors!
We’re excited to welcome all new subscribers to our English newsletter💌
∎ Celltrion posts record Q3 profit as high-margin biosimilars, merger boost growth - KED Global
∎ EYEGENE launches Phase 2 clinical trials for EG-MCV4, Korea’s first homegrown quadrivalent meningococcal vaccine candidate - THE BIO
∎ Samsung Biologics officially sheds biosimilar unit to expand as pure CMO - AJU Press
∎ GC Green Cross Wellbeing's "Longvida Turmeric Extract" Approved by Ministry of Food and Drug Safety as Functional Ingredient - The Asia Business Daily
∎ RP Bio Develops Turmeric-Based Ingredient to Fill Market Gap After Choline Drug Cuts - KOREA DUTY FREE NEWS
∎ Korea’s First Direct Drone Planting Technology Opens a New Chapter in Future Forest Restoration in Yeongwol - The Asia Business Daily
∎ Survey Reveals Growing Acceptance of Gene-Edited Foods in Korea - ISAAA
∎ Medical cannabis drives Korea natural drug industry growth with CBD therapies - Chosun Biz
∎ Naver, Kakao Expand into Digital Healthcare - Businesskorea
📰
Join our press list
Get KoreaBIO updates
& media resources
💬
Share Your thoughts!
How was your letter today?
✉️
Korean Newsletter
Daily biotech news from Korea and around the world
— in Korean
Explore More
KoreaBIO (Korea Biotechnology Industry Organization)
700 Daewangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea
+82-31-628-0037
수신거부 Unsubscribe